A company, including Bayer, reported strong interim results, citing success in its crop science business but also noting weaker demand for hip and knee implants.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company, including Bayer, reported strong interim results, citing success in its crop science business but also noting weaker demand for hip and knee implants.